A granulocytic sarcoma expanded the malar region in a patient with proven myelofibrosis over a 22 month period before undergoing rapid increase in size concomitantly with transformation to acute granulocytic leukaemia in the marrow and the widespread appearance of subcutaneous tumour deposits. Rapid response was obtained with local radiotherapy, and the systemic disease manifestations were controlled on combination courses of oral 4'-demethoxydaunorubicin and the epipodophyllotoxin VP16-213. This appears to be the first example of a granulocytic sarcoma occurring in a patient with myelofibrosis.
Introduction
Myeloblastoma appears to have been first described as a green tumour (Bums, 1823) and designated chloroma shortly thereafter (King, 1853) . The association with acute leukaemia was originally misinterpreted (Dock, 1893) as lymphoid, and it was not until 1903 (Turk, 1903 ) that the correct correlation was made with the granulocytic cell line. The terminology for these tissue-destroying tumour nodules has changed. Chloroma, due to the green colour conferred upon them by the myeloperoxidase that they contained (Agner, 1941) , is inappropriate since this is not a universal feature; myeloblastoma is also inexact, since the characteristic intracellular inclusions are not found in all patients. The preferred term is granulocytic sarcoma, based on the histological features of these neoplasms (Rappaport, 1966; Liu et al., 1973) .
Granulocytic sarcomas have been reported to arise in many organs, characteristically as relatively late manifestations in the course of acute or chronic granulocytic leukaemia. This appears to be the first description in a patient with myelofibrosis only.
Case report
A 54 year old woman presenting in 1973 with anaemia, weight loss, and 1 cm splenomegaly, had a diagnosis of myelofibrosis established on trephine biopsy. Five years later splenectomy was undertaken for increasing discomfort, pain due to infarction and increasing pancytopenia. Five years after the operation, whilst on titrated doses of hydroxyurea to control a rising granulocyte count, a non-tender firm swelling was noticed in the malar region of her face. Repeat trephine biopsy confirmed the presence in the bone marrow of myelofibrosis only. Radiological studies showed diffuse soft tissue swelling overlying the zygomatic process, with preservation of skeletal structures, including the sinuses. The tumour mass gradually increased in size over the next 18 months, became tethered to the underlying malar and maxilla but free ofthe overlying skin, and still without any radiological evidence of bone destruction.
At this time biopsy of enlarged groin glands showed granulocytic sarcoma, but marrow trephine biopsy again confirmed the presence of myelofibrosis only. The lymphadenopathy responded promptly to local radiotherapy. Haemoglobin was 8.1 g/dl, total white count 5.8 x 109/1, with 30% neutrophils, 37% lymphocytes, 16% monocytes, 8% myeloblasts, 1% promyelocytes, 4% myelocytes, 4% metamyelocytes and platelets 100 x 109/1; there were 164 nucleated red cells present for every 100 white cells counted.
Rapid swelling of the malar lesion now took place (Figure 1) , and a sublabial biopsy showed the classical morphological features of a granulocytic sarcoma. This was treated with local radiotherapy and the face returned to normal within 4 weeks. Widespread discrete granulocytic sarcomas were now evident, and for the first time haematological evidence of 
Discussion
Granulocytic sarcomas appear not to have been previously described in the myeloproliferative syndrome, although their occurrence might be anticipated during the acute terminal phase ofthese syndromes, as has not infrequently been reported with myeloblastic transformation. In its classical form this tumour arises in the course of acute myelogenous or monoblastic leukaemia. Although it has been described in many different anatomical sites including small bowel (Brugo et al., 1975) , breast mass during pregnancy (Sears & Reid, 1976) , cervix (Seo et al., 1977) , uterus (Kapadia et al., 1978) , ovary (Ballon et al., 1978) , and perineural and epidural structures (Muss & Moloney, 1973) , and in the eye and the orbit (Cavdar et al., 1978) , it does not appear to have been previously described as a soft tissue swelling in the malar region, where the present example is particularly remarkable for total preservation of skeletal structures in the area, including the sinuses. Furthermore, the presentation of a granulocytic sarcoma in patients with the myeloproliferative syndrome during the indolent phase of myelofibrosis, before clinical acceleration or myeloblastic transformation in the marrow has taken place, must be a unique event.
As a rule the tumours are radiosensitive and local treatment to the groin glands promptly returned them to normal; the same gratifying response was seen in the patient's face. In general, myeloblastic transformation in the course of chronic granulocytic leukaemia responds poorly to therapy and survival is short. It is therefore worth noting that the oral regimen of 4'-demethoxydaunorubicin in combination with the epipodophyllotoxin VP16-213 was dramatically effective and associated with only a transient period of marrow hypoplasia. Haematopoiesis regenerated without morphological evidence of acute leukaemia and although the period of follow-up is short, the convenience and efficacy of this regimen may warrant further evaluation.
